Skip to the page

Data / Form D filings / King Therapeutics LLC

King Therapeutics LLC: Form D filing

King Therapeutics LLC, a company in Phoenix, AZ, filed a Form D with the SEC in 2025. The latest, on October 15, 2025, reports $310,000 sold of a $500,000 offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
12006 S. 44TH ST., Phoenix, AZ, 85044
Phone
(602) 516-2199
Industry
Other
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2088073

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 15, 2025New notice$500,000$310,000$190,0007Jun 11, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David RichardsonExecutive Officer, Director
Isaiah SlemonsDirector
Dmitry DerkachDirector

Other companies in Arizona that filed recently

Every Form D from the week of Oct 13, 2025 · All recent filings in Arizona · All recent Other filings

Read from SEC EDGAR. Amount sold is what King Therapeutics LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.